Micron Technology, Inc. 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended May 30, 1996, and the nine-month period ended on that date. Micron Technology, Inc. is a manufacturer of semiconductor memory products and personal computer (PC) systems. The company is currently navigating a transition from 6-inch to 8-inch wafer processing and shifting its primary product focus from 4 Meg DRAM to 16 Meg DRAM.
Key Financial Metrics
| Metric | Q3 1996 | Q3 1995 | 9 Months 1996 | 9 Months 1995 |
|---|---|---|---|---|
| Net Sales ($ millions) | $771.0 | $761.2 | $2,953.3 | $1,924.7 |
| Net Income ($ millions) | $58.2 | $220.2 | $574.9 | $563.0 |
| Earnings Per Share (Diluted) | $0.27 | $1.02 | $2.66 | $2.62 |
| Gross Margin % | 27.6% | 53.1% | 44.2% | 55.9% |
| Operating Cash Flow (9mo) ($ millions) | $951.2 | $693.7 | ||
| Cash & Equivalents ($ millions) | $393.0 | $128.1 | N/A | |
| Total Debt ($ millions) | $469.2 | $155.9 | N/A |
Note: Total Debt includes short-term debt ($200.0M), current portion of long-term debt ($57.4M), and long-term debt ($211.8M) as of May 30, 1996.
Material Changes vs. Prior Period
- Profitability Decline: Q3 1996 net income dropped 73.6% compared to Q3 1995, despite a slight 1.3% increase in net sales. This was driven by a collapse in gross margins from 53.1% to 27.6%.
- Pricing Pressure: Average selling prices for the company's primary product, the 4 Meg DRAM, declined approximately 75% from late 1995 to Q3 1996 due to global supply outpacing demand.
- Product Mix Shift: Sales of PC systems increased to 36.4% of total net sales in Q3 1996 (from 17.2% in Q3 1995). While PC sales grew, they carry lower gross margins than semiconductor memory, dragging down overall profitability.
- Restructuring: A $29.9 million pre-tax restructuring charge was recorded in Q2 1996 (included in the 9-month period) to discontinue ZEOS brand PC systems and close related operations.
- Capital Expenditures: Spending on property, plant, and equipment surged to $1,275.9 million for the nine months ended May 30, 1996, compared to $451.7 million in the prior year period, primarily for 8-inch wafer conversion.
Outlook, Risks, and Management Commentary
- Liquidity and Debt: The company established a $500 million revolving credit facility, with $200 million outstanding as of May 30, 1996. Management is operating under a 60-day waiver for an EBITDA covenant while negotiating changes. There is no assurance that amended terms will be acceptable or that full borrowing capacity will be available.
- Capital Expenditure Guidance: Q4 1996 capital expenditures are expected to be between $200 million and $300 million, focused on completing the Fab I/II conversion to 8-inch wafers. The Lehi, Utah facility construction is on indefinite hold.
- Product Transition Risk: The transition to 16 Meg DRAM is expected in Fall 1996. Management warns this transition could negatively impact results and cash flows, as seen in previous generation shifts.
- Market Risks: The semiconductor industry is highly cyclical. Continued downward pressure on DRAM prices and the inability to reduce costs per part at the same rate as price declines could materially adversely affect operations.
- Legal Contingencies: The company faces potential patent infringement claims. While liabilities have been accrued, management cannot estimate the range of additional possible losses, which could require material changes to production processes.
Investor Verification Checklist
- Verify the status of the 60-day covenant waiver on the $500 million credit facility and the terms of the renegotiated agreement.
- Monitor the timeline and yield rates for the conversion of Fab I/II to 8-inch wafers, as delays could impact cost structures.
- Track the average selling price (ASP) trends for 4 Meg DRAM versus the ramp-up of 16 Meg DRAM to assess margin recovery potential.
- Review the progress of the PC systems business (Micron brand) to determine if volume growth can offset lower margins.
- Assess the adequacy of accrued liabilities for patent infringement claims given the competitive nature of the industry.